Review ArticleJournal of Young PharmacistsVol. 9 | Issue 2 | 2017 | pp. 140–144Open access
Comparison of Adverse Effects of Newer Atypical Antipsychotics: An Evidence Based Review
- 1*,
- 2,
- 1
- 1 Department of Pharmacology, Pramukh Swami Medical College, Karamsad, Gujarat, INDIA.
- 2 Medical Affairs Division, Wockhardt Ltd., Mumbai, Maharashtra, INDIA.
Published in Journal of Young Pharmacists
Correspondence: Kharadi Dhruvika Gaurang
Department of Pharmacology, Pramukh Swami Medical College, Karamsad, Gujarat, INDIA.
Email: dgkharadi@yahoo.co.in
Copyright: © 2017 Manuscript Technomedia. This is an open access article.
- Published:
- Apr 23, 2017
- Received:
- Jul 6, 2016
- Accepted:
- Jan 2, 2017
How to cite
Gaurang, K. D., Rajendra, S. A., & Barna, G. (2017). Comparison of Adverse Effects of Newer Atypical Antipsychotics: An Evidence Based Review. Journal of Young Pharmacists, 9(2), 140–144. https://doi.org/10.5530/jyp.2017.9.29
Abstract
Aim: To Compare the safety of asenapine and iloperidone as per informa tion available in public domain. Method: In addition to their USFDA ap proved prescribing information, literature on these two drugs from Pubmed indexed journals in English language were searched for appropriate information. We found 8 relevant articles on asenapine and iloperidone, results of which are discussed in this review. Data on the adverse effects commonly reported for atypical antipsychotics were collected from these articles and compared. Descriptive statistics was used to present the re sults. Results: Iloperidone is more frequently found to be associated with QTc prolongation (dose dependent), orthostatic hypotension & related dizziness (despite slow up-titration), weight gain and antimuscarinic side effects. On other side, asenapine is more frequently associated with extra pyramidal side effects and akathisia as well as the only one associated with headache, oral hypoesthesia and adverse event related discontinuations. Conclusion: Although, asenapine appears to be less frequently associated with adverse events commonly associated with atypical antipsychotics, complex sublingual dosing and higher discontinuation related to adverse events offsets this safety advantage. More importantly, both these agents require close counselling of patients for adequate compliance and/ or com bination with other antipsychotic to achieve optimum antipsychotic efficacy in Indian context.
Keywords
Subject
Article metadata
| Title | Comparison of Adverse Effects of Newer Atypical Antipsychotics: An Evidence Based Review |
|---|---|
| Authors | Kharadi Dhruvika Gaurang; Shah Agam Rajendra; Ganguly Barna |
| Affiliations | Department of Pharmacology, Pramukh Swami Medical College, Karamsad, Gujarat, INDIA.; Medical Affairs Division, Wockhardt Ltd., Mumbai, Maharashtra, INDIA. |
| Corresponding author | dgkharadi@yahoo.co.in |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 9, Issue 2 (2017) |
Also in this issue
- Highly Cited Publications Output by India in Clinical Pharmacology during 2000-14: A Scientometric Assessmentpp. 145–157
- Design, Synthesis and Characterization of Benzothiazole Analogues as Promising Pharmacological Agentspp. 158–161
- 3D QSAR Studies on Some 5-(1H-Indol-5-yl)-1, 3, 4-Thiadiazol-2 Amines as Potential PIM-1 Inhibitorspp. 162–167
- In-Silico Screening of Flavonoids Targeted for Death Receptors in Cancer by Using Hex Molecular Dockingpp. 168–171
- Synthesis of Chitosan-Graft- HPβCD Copolymer by Novel One Pot Technique and its Application for Solubility Enhancement of Efavirenzpp. 172–176
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026